Trial Details

TERMINATED
Basic Information
Clinical ID c2746
Identifier NCT03017014
Trial Title A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions -
Participant Information
Sponsor AbbVie
City Auvergne-Rhône-Alpes
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2017-09-26
Primary Completion Date 2019-10-14
Completion Date 2019-10-14